{"id":"https://openalex.org/W7224112381","doi":"https://doi.org/10.21037/tcr-2026-1598","title":"Messenger RNA vaccine platforms from molecular optimization to infectious disease and cancer immunotherapy: a narrative review","display_name":"Messenger RNA vaccine platforms from molecular optimization to infectious disease and cancer immunotherapy: a narrative review","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7224112381","doi":"https://doi.org/10.21037/tcr-2026-1598","pmid":"https://pubmed.ncbi.nlm.nih.gov/42997904","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13743248"},"language":"en","primary_location":{"id":"doi:10.21037/tcr-2026-1598","doi":"https://doi.org/10.21037/tcr-2026-1598","is_oa":true,"landing_page_url":"https://doi.org/10.21037/tcr-2026-1598","pdf_url":null,"source":{"id":"https://openalex.org/S2764965054","display_name":"Translational Cancer Research","issn_l":"2218-676X","issn":["2218-676X","2219-6803"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310321814","host_organization_name":"AME Publishing Company","host_organization_lineage":["https://openalex.org/P4310321814"],"host_organization_lineage_names":["AME Publishing Company"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Cancer Research","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.21037/tcr-2026-1598","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160002882","display_name":"Qian Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161350542","display_name":"China Three Gorges University","ror":"https://ror.org/0419nfc77","country_code":"CN","type":"education","lineage":["https://openalex.org/I161350542"]},{"id":"https://openalex.org/I4210152080","display_name":"Yichang Central People's Hospital","ror":"https://ror.org/04cr34a11","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210152080"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Qian Wang","raw_affiliation_strings":["Affiliated Central People's Hospital, China Three Gorges University, Yichang, China","Institute of Pharmaceutic Preparation, China Three Gorges University, Yichang, China","Yichang Central People's Hospital, Yichang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affiliated Central People's Hospital, China Three Gorges University, Yichang, China","institution_ids":["https://openalex.org/I161350542","https://openalex.org/I4210152080"]},{"raw_affiliation_string":"Institute of Pharmaceutic Preparation, China Three Gorges University, Yichang, China","institution_ids":["https://openalex.org/I161350542"]},{"raw_affiliation_string":"Yichang Central People's Hospital, Yichang, China","institution_ids":["https://openalex.org/I4210152080"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160024807","display_name":"Zhangzhang Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139780","display_name":"Yixing People's Hospital","ror":"https://ror.org/049avne82","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210139780"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhangzhang Sun","raw_affiliation_strings":["Yixing People's Hospital, Yixing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yixing People's Hospital, Yixing, China","institution_ids":["https://openalex.org/I4210139780"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5129875522","display_name":"Heyong Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103309","display_name":"Ezhou Central Hospital","ror":"https://ror.org/00vx54857","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103309"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Heyong Liu","raw_affiliation_strings":["Department of Pharmacy, Ezhou Central Hospital, Ezhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Ezhou Central Hospital, Ezhou, China","institution_ids":["https://openalex.org/I4210103309"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5160002882"],"corresponding_institution_ids":["https://openalex.org/I161350542","https://openalex.org/I4210152080"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.49514088,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"15","issue":"10","first_page":"789","last_page":"789"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9535999894142151,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9535999894142151,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.030799999833106995,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10521","display_name":"RNA and protein synthesis mechanisms","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mrna-vaccines","display_name":"mRNA vaccines","score":0.9319999814033508},{"id":"https://openalex.org/keywords/self-amplifying-rna","display_name":"self-amplifying RNA","score":0.859000027179718},{"id":"https://openalex.org/keywords/circular-rna","display_name":"circular RNA","score":0.8799999952316284},{"id":"https://openalex.org/keywords/lipid-nanoparticles","display_name":"lipid nanoparticles","score":0.7289999723434448},{"id":"https://openalex.org/keywords/mrna-delivery","display_name":"mRNA delivery","score":0.3799999952316284},{"id":"https://openalex.org/keywords/infectious-disease-vaccines","display_name":"infectious disease vaccines","score":0.6660000085830688},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.9319999814033508},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.878000020980835},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8479999899864197},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9819999933242798},{"id":"https://openalex.org/keywords/t-cell-response","display_name":"T cell response","score":0.4259999990463257}],"concepts":[{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.6445000171661377},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5740000009536743},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5066999793052673},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5005000233650208},{"id":"https://openalex.org/C3020000205","wikidata":"https://www.wikidata.org/wiki/Q2412849","display_name":"Narrative review","level":2,"score":0.4830999970436096},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4372999966144562},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.39879998564720154},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.3905999958515167},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38999998569488525},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3849000036716461},{"id":"https://openalex.org/C2778378633","wikidata":"https://www.wikidata.org/wiki/Q2378309","display_name":"Cancer vaccine","level":4,"score":0.3529999852180481},{"id":"https://openalex.org/C179786068","wikidata":"https://www.wikidata.org/wiki/Q16257937","display_name":"Molecular diagnostics","level":2,"score":0.352400004863739},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3456999957561493},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.3433000147342682},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33809998631477356},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.33070001006126404},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.323199987411499},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.31040000915527344},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.30469998717308044},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3009999990463257},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.29580000042915344},{"id":"https://openalex.org/C21786251","wikidata":"https://www.wikidata.org/wiki/Q14886350","display_name":"RNA editing","level":4,"score":0.2935999929904938},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2720000147819519},{"id":"https://openalex.org/C108759981","wikidata":"https://www.wikidata.org/wiki/Q788590","display_name":"Authorization","level":2,"score":0.26930001378059387},{"id":"https://openalex.org/C128972844","wikidata":"https://www.wikidata.org/wiki/Q418722","display_name":"Aptamer","level":2,"score":0.2632000148296356},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.250900000333786}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.21037/tcr-2026-1598","doi":"https://doi.org/10.21037/tcr-2026-1598","is_oa":true,"landing_page_url":"https://doi.org/10.21037/tcr-2026-1598","pdf_url":null,"source":{"id":"https://openalex.org/S2764965054","display_name":"Translational Cancer Research","issn_l":"2218-676X","issn":["2218-676X","2219-6803"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310321814","host_organization_name":"AME Publishing Company","host_organization_lineage":["https://openalex.org/P4310321814"],"host_organization_lineage_names":["AME Publishing Company"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Cancer Research","raw_type":"journal-article"},{"id":"pmid:42997904","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42997904","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational cancer research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.21037/tcr-2026-1598","doi":"https://doi.org/10.21037/tcr-2026-1598","is_oa":true,"landing_page_url":"https://doi.org/10.21037/tcr-2026-1598","pdf_url":null,"source":{"id":"https://openalex.org/S2764965054","display_name":"Translational Cancer Research","issn_l":"2218-676X","issn":["2218-676X","2219-6803"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310321814","host_organization_name":"AME Publishing Company","host_organization_lineage":["https://openalex.org/P4310321814"],"host_organization_lineage_names":["AME Publishing Company"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7168160252","https://openalex.org/W7221038502","https://openalex.org/W7213527448","https://openalex.org/W7165397212","https://openalex.org/W7216144148","https://openalex.org/W4401690989","https://openalex.org/W7155189428","https://openalex.org/W4387673314","https://openalex.org/W7211955831","https://openalex.org/W4401328477"],"abstract_inverted_index":{"Background":[0],"and":[1,18,40,68,94,108,133,139,167,172,184,193,198,214,260,307,318,321,325],"Objective:":[2],"Messenger":[3],"RNA":[4,47,64,126,129,176,291],"(mRNA)":[5],"vaccines":[6,330],"now":[7,156],"encompass":[8],"licensed":[9],"respiratory":[10],"vaccines,":[11],"a":[12],"self-amplifying":[13,125],"ribonucleic":[14],"acid":[15],"(RNA)":[16],"product,":[17],"individualized":[19,134,332],"cancer":[20,69],"immunotherapies":[21],"in":[22,84,145,207,230],"late-stage":[23],"development.":[24],"The":[25],"expansion":[26],"of":[27,97,174,236,270],"the":[28,46,53,149,255,268,284,310],"field":[29],"has":[30,180,223],"made":[31],"platform-level":[32],"comparisons":[33],"increasingly":[34],"important":[35,266],"because":[36],"efficacy,":[37],"tolerability,":[38],"manufacturability,":[39],"tissue":[41],"targeting":[42],"are":[43,263],"influenced":[44],"by":[45,52,91],"architecture":[48,292],"as":[49,51,265,267],"well":[50],"delivery":[54,308],"system.":[55],"This":[56],"narrative":[57],"review":[58],"examines":[59],"molecular":[60,131],"engineering,":[61],"delivery,":[62],"emerging":[63],"architectures,":[65],"infectious-disease":[66,329],"translation,":[67],"immunotherapy,":[70],"with":[71],"emphasis":[72],"on":[73,124,303],"developments":[74],"reported":[75],"through":[76,86],"2026.":[77],"Methods:":[78],"Targeted":[79],"literature":[80],"searches":[81,96],"were":[82,111],"conducted":[83],"PubMed":[85],"31":[87],"August":[88],"2026,":[89],"complemented":[90],"reference":[92],"chaining":[93],"targeted":[95],"official":[98],"regulatory":[99,106,182,215,326],"sources.":[100],"English-language":[101],"mechanistic":[102],"studies,":[103],"clinical":[104,299],"trials,":[105],"documents,":[107],"focused":[109],"reviews":[110],"prioritized.":[112],"Particular":[113],"attention":[114],"was":[115],"given":[116],"to":[117,122,161,309,331],"evidence":[118],"published":[119],"from":[120,328],"2023":[121],"2026":[123],"(saRNA),":[127],"circular":[128],"(circRNA),":[130],"optimization,":[132],"neoantigen":[135,251,278],"vaccines.":[136],"Key":[137],"Content":[138],"Findings:":[140],"Nucleoside-modified":[141],"non-replicating":[142],"mRNA":[143],"formulated":[144],"lipid":[146,210],"nanoparticles":[147],"remains":[148,190],"most":[150],"clinically":[151],"validated":[152,323],"architecture.":[153],"Molecular":[154],"optimization":[155],"extends":[157],"beyond":[158],"nucleoside":[159],"substitution":[160],"cap":[162],"chemistry,":[163],"untranslated-region":[164],"selection,":[165],"coding-sequence":[166],"RNA-structure":[168],"design,":[169,209],"poly(A)":[170],"control,":[171],"removal":[173],"double-stranded":[175],"(dsRNA)":[177],"impurities.":[178],"saRNA":[179],"reached":[181],"authorization":[183],"offers":[185],"dose-sparing":[186],"potential,":[187],"whereas":[188],"circRNA":[189],"predominantly":[191],"preclinical":[192],"still":[194],"faces":[195],"unresolved":[196],"manufacturing":[197,261,324],"quality-control":[199],"questions.":[200],"Infectious-disease":[201],"programs":[202],"have":[203],"established":[204],"reusable":[205],"capabilities":[206,327],"antigen":[208,253,316],"nanoparticle":[211],"formulation,":[212],"manufacturing,":[213],"comparability.":[216],"In":[217],"oncology,":[218],"intismeran":[219],"autogene":[220,237],"plus":[221],"pembrolizumab":[222],"produced":[224],"durable":[225],"recurrence-free":[226],"survival":[227],"(RFS)":[228],"benefit":[229],"resected":[231],"melanoma,":[232],"while":[233],"pancreatic-cancer":[234],"studies":[235],"cevumeran":[238],"show":[239],"that":[240,336],"vaccine-induced":[241],"T":[242],"cell":[243],"responses":[244],"vary":[245],"substantially":[246],"between":[247],"patients.":[248],"Tumor":[249],"clonality,":[250],"quality,":[252],"presentation,":[254],"immune":[256,312],"microenvironment,":[257],"treatment":[258],"setting,":[259],"time":[262],"therefore":[264],"number":[269],"encoded":[271],"mutations.":[272],"Artificial":[273],"intelligence":[274],"(AI)":[275],"can":[276],"improve":[277],"ranking":[279],"but":[280],"does":[281],"not":[282],"remove":[283],"need":[285],"for":[286,342],"biological":[287],"validation.":[288],"Conclusions:":[289],"No":[290],"is":[293,340],"uniformly":[294],"superior":[295],"across":[296],"indications.":[297],"Further":[298],"progress":[300],"will":[301],"depend":[302],"matching":[304],"transcript":[305],"design":[306],"intended":[311],"response,":[313],"improving":[314],"predictive":[315],"selection":[317],"patient":[319],"stratification,":[320],"transferring":[322],"oncology":[333],"without":[334],"assuming":[335],"platform":[337],"maturity":[338],"alone":[339],"sufficient":[341],"antitumor":[343],"efficacy.":[344]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-10-29T00:00:00"}